05/27/2002 By David Loshak
Selective serotonin reuptake inhibitors relieve dizziness in patients with major or minor psychiatric symptoms such as peripheral vestibular conditions and migraines.
Patients fare much better with selective serotonin reuptake inhibitors than with vestibular suppressants or benzodiazepines, say researchers at the University of Pennsylvania, Philadelphia, United States.
They investigated the efficacy and tolerability of selective serotonin reuptake inhibitors (SSRIs) for the treatment of patients with dizziness and major or minor psychiatric symptoms with or without neurotological illnesses (neurological conditions of the ear).
Sixty consecutive cases of male and female patients, aged 13-81 years, with dizziness who were treated with a selective serotonin reuptake inhibitor for at least 20 weeks were reviewed.
The patients had either psychogenic dizziness, dizziness due to a neurotological condition as
well as significant psychiatric symptoms, or idiopathic dizziness.
e-Med Tools
קצר קולע וממוקד
e-Med סמינרים
אי-מד תחקירים
Medscape Tools
Journal Club
מרכזי מידע ושירות
Facebook
מידע למפרסם
מאגר תרופות
מאגר אנשי המקצוע
אינדקס שימושי
חדשות משה"ב
eMed HealthClub
מחקרים קליניים
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!